Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The Centre for Rehabilitation Research in Oxford (RRIO) led by Professor Sallie Lamb of NDORMS has been awarded £2 million by the National Institute for Health Research (NIHR) to look at improving the management of lower back pain in older people.

The Centre for Rehabilitation Research in Oxford (RRIO) lead by Professor Sallie Lamb of NDORMS has been awarded £2 million by the National Institute for Health Research (NIHR) to look at improving the management of lower back pain in older people.

Lower back pain is now recognised as the leading disabling condition in the world, with over 70% of people suffering with it in their lifetime. Older people in particular are at higher risk of having the most serious forms of lower back pain, leading to mobility decline and falls, as well as frailty and loss of independence – a key concern for this age group.

Despite this, lower back pain in older people is often ignored, missed or mismanaged in primary care. Both patients and their GPs may dismiss treatment for lower back pain, instead accepting it as part of ageing and prioritising the treatment of other health conditions. In addition, although there is a large amount of research on back pain, older people are often excluded from these studies.

The BOOST programme of research (Better Outcomes for Older People with Spinal Trouble) will help primary health care clinicians, patients and their carers recognise when to prioritize the treatment of back pain , and to explore and hopefully counter prejudices held by older people and clinicians.  It will also evaluate a physiotherapy programme for people with neurogenic claudication, a condition arising from ageing changes within the spine, which is common in older people and can severely limit their ability to walk and stand.  

Dr Esther Williamson, NDORMS Research Fellow and project lead says: "Remaining independent is the key concern for older people. Through this work we want to develop evidence based treatment strategies as well as an improved understanding of prognosis and greater knowledge about back pain in older people. By developing effective treatments we hope to reduce pain but also have an impact on broader health outcomes, helping older people to remain active and independent and preventing falls and frailty."

If you’d like to find out more about this study or be involved, please contact Esther and the BOOST research team at BOOST@ndorms.ox.ac.uk

 

Similar stories

NDORMS researchers awarded grant for study on the effects of COVID-19 vaccines on long COVID

A team of NDORMS researchers including Doctor Annika Jödicke and Doctor Victoria Strauss have been awarded NIHR funding to carry out a study into the effects of different COVID-19 vaccines on long COVID.

Treatment choice for rotator cuff disorders could create efficiency and savings for the NHS

A trial that evaluated the clinical and cost effectiveness of physiotherapy treatments for rotator cuff disorders suggests cost savings can be made while maintaining positive patient outcomes.

Exploring the link between joint injury and osteoarthritis

A new study published in The Lancet Rheumatology shows potential ways to predict how likely someone is to develop osteoarthritis after a knee injury.

COVID-19 vaccine safety monitoring should account for age, gender, and database differences

The largest, most extensive global network study on background rates for adverse events of special interest identifies important age, sex and database differences that should inform future safety surveillance efforts.

Research finds that surgery for Dupuytren’s disease is effective, but repeat operations come with higher risks

Research by NDORMS Dominic Furniss, Professor of Plastic and Reconstructive Surgery, finds that surgery for the common hand disorder Dupuytren’s disease is safe and effective. However, repeat surgery could carry higher risks of complications such as finger amputation.